header
Image from OpenLibrary

The use of ursodeoxycholic acid in prevention of cholelithiasis following laparoscopic vertical sleeve gastrectomy / Mohamed Abdelmageed Abdelkader Elfiky ; Supervised Amr Yehia Elshayeb , Nader Makram Milad , Karim Kamal Maurice

By: Contributor(s): Material type: TextTextLanguage: English Publication details: Cairo : Mohamed Abdelmageed Abdelkader Elfiky , 2021Description: 65 P. : charts , facsimiles ; 25mOther title:
  • استخدام حامض الاورسودى اوكسى كول{u٠٦أأ}ك لمنع تكو{u٠٦أأ}ن الحصوات بالمرارة بعد عمل{u٠٦أأ}ة تكميم المعدة [Added title page title]
Subject(s): Available additional physical forms:
  • Issued also as CD
Dissertation note: Thesis (Ph.D.) - Cairo University - Faculty of Medicine - Department of General Surgery Summary: Background: Bariatric surgery is considered a successful modality for long-term maintaining weight loss, Rapid weight loss following these procedures is associated with increased incidence of postoperative Cholelithiasis (CL).Postoperative use of ursodeoxycholic acid (UDCA) was advocatedto prevent gallstone formation during the postoperative period and to avoid the unnecessary morbidities that occur with routine prophylactic cholecystectomy performed in bariatric surgery patients even in absence of gallstones. The aim of this study was to evaluate the role of daily administration of ursodeoxycholic acid (UDCA) for 6 months in the prevention of CL after laparoscopic sleeve gastrectomy Methods This was a prospective randomized control trial of 80 morbidly obese patients who underwent laparoscopic sleeve gastrectomy after preoperative ultrasonographic exclusion of gallstones. Patients were subdivided into two groups: control group (No UDCA group) who did not receive prophylactic treatment with UDCA, and UDCA group, who received 500mg of UDCA therapy for 6 months postoperatively.Patient{u2019}s characteristics, weight loss data, any detectable complications and incidence of CL at 6 ,12, and 18 months postoperatively were collected
Tags from this library: No tags from this library for this title. Log in to add tags.
Star ratings
    Average rating: 0.0 (0 votes)
Holdings
Item type Current library Home library Call number Copy number Status Date due Barcode
Thesis Thesis قاعة الرسائل الجامعية - الدور الاول المكتبة المركزبة الجديدة - جامعة القاهرة Cai01.11.14.Ph.D.2021.Mo.U (Browse shelf(Opens below)) Not for loan 01010110084953000
CD - Rom CD - Rom مخـــزن الرســائل الجـــامعية - البدروم المكتبة المركزبة الجديدة - جامعة القاهرة Cai01.11.14.Ph.D.2021.Mo.U (Browse shelf(Opens below)) 84953.CD Not for loan 01020110084953000

Thesis (Ph.D.) - Cairo University - Faculty of Medicine - Department of General Surgery

Background: Bariatric surgery is considered a successful modality for long-term maintaining weight loss, Rapid weight loss following these procedures is associated with increased incidence of postoperative Cholelithiasis (CL).Postoperative use of ursodeoxycholic acid (UDCA) was advocatedto prevent gallstone formation during the postoperative period and to avoid the unnecessary morbidities that occur with routine prophylactic cholecystectomy performed in bariatric surgery patients even in absence of gallstones. The aim of this study was to evaluate the role of daily administration of ursodeoxycholic acid (UDCA) for 6 months in the prevention of CL after laparoscopic sleeve gastrectomy Methods This was a prospective randomized control trial of 80 morbidly obese patients who underwent laparoscopic sleeve gastrectomy after preoperative ultrasonographic exclusion of gallstones. Patients were subdivided into two groups: control group (No UDCA group) who did not receive prophylactic treatment with UDCA, and UDCA group, who received 500mg of UDCA therapy for 6 months postoperatively.Patient{u2019}s characteristics, weight loss data, any detectable complications and incidence of CL at 6 ,12, and 18 months postoperatively were collected

Issued also as CD

There are no comments on this title.

to post a comment.